C. Dehnert

发表

High-altitude pulmonary edema and patent foramen ovale.

E. Grünig, C. Dehnert, P. Bärtsch, 2007, JAMA.

Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m)

W. Haefeli, Michael Streit, G. Mikus, 2005, European Journal of Clinical Pharmacology.

ACUTE MOUNTAIN SICKNESS AND HIGH-ALTITUDE CEREBRAL EDEMA

P. Hackett, R. Roach, C. Dehnert, 2003 .

Increased hepcidin levels in high-altitude pulmonary edema.

M. Muckenthaler, G. Weiss, C. Dehnert, 2015, Journal of applied physiology.

No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m

P. Vock, G. Hahn, D. Bailey, 2009, European Respiratory Journal.

Microhemorrhages in Nonfatal High-Altitude Cerebral Edema

K. Kallenberg, M. Knauth, P. Schellinger, 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

pulmonary edema epithelium in mountaineers with high-altitude Altered ion transporter expression in bronchial

D. Bailey, C. Dehnert, P. Bärtsch, 2015 .

No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.

C. Dehnert, P. Bärtsch, H. Mairbäurl, 2011, High altitude medicine & biology.

Sleeping in Moderate Hypoxia at Home for Prevention of Acute Mountain Sickness (AMS): A Placebo-Controlled, Randomized Double-Blind Study

C. Dehnert, P. Bärtsch, E. Menold, 2014, Wilderness & environmental medicine.

High‐altitude pulmonary hypertension is associated with a free radical‐mediated reduction in pulmonary nitric oxide bioavailability

I. Young, D. Bailey, E. Swenson, 2010, The Journal of physiology.

Effects of intermittent hypoxia training on exercise performance, hemodynamics, and ventilation in healthy senior men.

D. Bailey, E. Swenson, C. Dehnert, 2009, High altitude medicine & biology.

Unchanged anaerobic and aerobic performance after short-term intermittent hypoxia.

C. Dehnert, P. Bärtsch, V. Tadibi, 2007, Medicine and science in sports and exercise.

Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease

G. Parati, B. Levine, W. Cornwell, 2021, Journal of the American Heart Association.

Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema

C. Dehnert, M. Maggiorini, M. Hilty, 2016, Mediators of inflammation.

Exaggerated hypoxic pulmonary vasoconstriction without susceptibility to high altitude pulmonary edema.

P. Vock, D. Albers, E. Grünig, 2015, High altitude medicine & biology.

Can patients with coronary heart disease go to high altitude?

C. Dehnert, P. Bärtsch, 2010, High altitude medicine & biology.

Enhanced hypoxic pulmonary vasoconstriction in families of adults or children with idiopathic pulmonary arterial hypertension.

B. Janssen, H. Olschewski, E. Grünig, 2005, Chest.

Erythropoiesis and Performance after Two Weeks of Living High and Training Low in Well Trained Triathletes

M. Lehmann, D. Böning, C. Dehnert, 2002, International journal of sports medicine.

in subjects exposed to high altitude Evidence against an increase in capillary permeability

M. Muckenthaler, P. Vock, Mao-tsun Lin, 2015 .

Does High Alveolar Fluid Reabsorption Prevent HAPE in Individuals with Exaggerated Pulmonary Hypertension in Hypoxia?

Theresa Betz, C. Dehnert, P. Bärtsch, 2015, High altitude medicine & biology.

Transpulmonary plasma catecholamines in acute high-altitude pulmonary hypertension.

D. Bailey, E. Swenson, C. Dehnert, 2011, Wilderness & environmental medicine.

The Hen or the Egg: Impaired Alveolar Oxygen Diffusion and Acute High-altitude Illness?

C. Dehnert, H. Mairbäurl, M. Sareban, 2019, International journal of molecular sciences.

Response to: Comment on “Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema”

C. Dehnert, M. Maggiorini, M. Hilty, 2018, Mediators of inflammation.

K+ channel activation with minoxidil stimulates nasal-epithelial ion transport and blunts exaggerated hypoxic pulmonary hypertension.

C. Dehnert, P. Bärtsch, C. Karle, 2006, High altitude medicine & biology.

High altitude pulmonary edema: A pressure-induced leak

C. Dehnert, P. Bärtsch, H. Mairbäurl, 2007, Respiratory Physiology & Neurobiology.

Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans.

Derliz Mereles, Hans-Ulrich Kauczor, Michael Puderbach, 2006, American journal of respiratory and critical care medicine.

Acute in vitro hypoxia and high-altitude (4,559 m) exposure decreases leukocyte oxygen consumption.

D. Bailey, E. Swenson, C. Dehnert, 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema

K. Bloch, R. Naeije, H. Brunner-La Rocca, 2006, Annals of Internal Medicine.

No association between high-altitude tolerance and the ACE I/D gene polymorphism.

U. Scherrer, C. Dehnert, P. Bärtsch, 2002, Medicine and science in sports and exercise.

Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension.

H. Katus, C. Dehnert, P. Bärtsch, 2007, Respiratory medicine.

Genetic Predisposition to High-Altitude Pulmonary Edema.

C. Fischer, C. Eichstaedt, E. Grünig, 2020, High altitude medicine & biology.

Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema.

Malte Kelm, Walter E Haefeli, W. Haefeli, 2005, American journal of respiratory and critical care medicine.

IDENTIFICATION OF SUBJECTS SUSCEPTIBLE TO HIGH ALTITUDE PULMONARY EDEMA (HAPE) BY DOPPLER ECHOCARDIOGRAPHY DURING EXERCISE IN NORMOXIA AND HYPOXIA

C. Dehnert, D. Mereles, A. Abushi, 2002 .

Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m.

C. Dehnert, P. Bärtsch, Kai Schommer, 2010, High altitude medicine & biology.

exposure decreases leukocyte oxygen consumption Acute in vitro hypoxia and high-altitude (4,559 m)

D. Bailey, C. Dehnert, P. Bärtsch, 2016 .

Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude

E. Grünig, C. Dehnert, P. Bärtsch, 2005, European Respiratory Journal.

Intermittent hypoxia at rest for improvement of athletic performance

B. Friedmann-Bette, C. Dehnert, P. Bärtsch, 2008, Scandinavian journal of medicine & science in sports.

Effect of „Living High-Training Low” on the Cardiac Functions at Sea Level

M. Lehmann, C. Dehnert, J. Steinacker, 1998, International journal of sports medicine.

Altered Left Ventricular Geometry and Torsional Mechanics in High Altitude‐Induced Pulmonary Hypertension: A Three‐Dimensional Echocardiographic Study

P. Buser, B. Kaufmann, C. Dehnert, 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

WHO GETS HIGH ALTITUDE PULMONARY EDEMA AND WHY

C. Dehnert, P. Bärtsch, H. Mairbäurl, 2007 .

[Acute Mountain Sickness and High-Altitude Cerebral Edema].

C. Dehnert, P. Bärtsch, 2017, Therapeutische Umschau. Revue therapeutique.

Intermittent hypoxia at rest for improvement of athletic performance

B. Friedmann-Bette, C. Dehnert, P. Bärtsch, 2008, Scandinavian journal of medicine & science in sports.

Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high‐altitude induced pulmonary hypertension at 4559 m

C. Dehnert, D. Mereles, S. Greiner, 2024, Echocardiography.